Yub Raj Neupane M.Pharma, Sem Ii Pharmaceutics Jamia Hamdard, New Delhi
Yub Raj Neupane M.Pharma, Sem Ii Pharmaceutics Jamia Hamdard, New Delhi
Yub Raj Neupane M.Pharma, Sem Ii Pharmaceutics Jamia Hamdard, New Delhi
GMP is.
.. that part of Quality Assurance which ensure that products are consistently produced and controlled to the quality standards appropriate to their use. GMP is an integral part of Quality Assurance
QA
GMP
QC
Employee Protection
Fulfilling Legal Requirements Good Business Practice Pride in Workplace
2) 21 CFR 100-169. General regulations for food labeling (contains the new regulations for nutrition labeling). Infant formula quality control procedures and labeling. Food standards and quality standards for bottled drinking water. The CGMP regulations for food, bottled drinking water, low-acid canned foods, and acidified foods.
5) 21 CFR 300-499. Drugs for human use. 6) 21 CFR 500-599. Animal drugs, feeds, and related products. 7) 21 CFR 600-799. Biologics and cosmetics.
8) 21 CFR 800-1299. Medical devices, radiological health, and control of communicable diseases. Import Milk Act, Federal Tea Importation Act, and Federal Caustic Poison Act.
9) 21 CFR 1300-End. Regulations implementing the Controlled Substances Act and the Controlled Substances Import and Export Act.
INTRODUCTION
A draft of GMP regulations was prepared in 1975 which was implemented in 1988 in the form of amended Schedule M. GMPs form the heart of quality. GMPs comprises a set of practices that ensures quality at every level of operation in an industry. GMPs provide quality assurances that off-the-shelf testing cant.
Subparts of Schedule-M
Subpart: A Finished Pharmaceuticals: General Provision B Organization and Personnel C Building and Facilities D Equipments E Control of Components and Drug Product Container and Closure F Production and Process Control G Packaging and Labeling Control H Holding and Distribution I Laboratory Control J Records and Report
SUBPART-C and D
Premises
Principle Principle PremisePrinciple Premises must be loPrinciple Premiseslocated, designed, constructed, adapted and maintained forconstructed, Premises must be must be located, designed, the operations: Minimize risks of errors and cross-contamination adapted and maintained for the operations: Permit effective cleaning Permit effective maintenance Minimize build-up dirt and dust Minimizeofrisks on quality Eliminate any adverse effects of errors and cross cated, designed, constructed, adapted and maintained for the operations: contamination and cross-contamination Minimize risks of errors Permit effective cleaning Permit effective maintenance Permit effective cleaning Minimize build-up of dirt and dust Eliminate any adverse effects on quality s must be located, designed, constructed, adapted and maintained for the operations: Permit effective maintenance Minimize risks of errors and cross-contamination Permit effective cleaning Minimize build-up of dirt and dust Permit effective maintenance Minimize build-up of dirt and dust Eliminate any adverse effects on quality Eliminate any adverse effects on quality
Principle Premises must be located to minimize risks of crosscontamination; e.g. not located next to a malting factory with high airborne levels of yeast
Location
Pollution/effluent control
Premises should be built to: Facilitate sanitation. Be maintained and cleaned easily Services availability Protection against entry of insects or other animals
Specific areas
Storage areas
Weighing areas
Production areas
Storage areas Appropriate temperature and relative humidity conditions within defined limits Provided, controlled, monitored and recorded Good storage conditions: clean, dry and appropriate lights Separate area for narcotics in locked room.
Weighing areas:
Weighing operations in separated areas Appropriate design (see also training material on HVAC) Provision for dust control Smooth, impervious, durable, easy-to-clean finishes
Operations relating to the manufacture, processing, and packing of penicillin shall be performed in facilities separate from those used for other drug products for human use.
Not These
These pictures illustrate a much better approach to achieving smooth, impervious durable surfaces for floors, walls and ceilings. The light fixtures fit flush with the ceiling, the floor uses welded vinyl which is covered to the wall face are very smooth and easy to clean and there are no gaps
Methods to reduce cross-contamination : 1. 2. 3. 4. 5. 6. 7. 8. Segregated areas Airlocks and pressure differentials Treatment of re-circulated air Protective clothing Effective cleaning procedures Closed production systems Residue testing Status labelling
Manufacturing and Packaging I Pipe work and other fittings sited to avoid recesses Drain design:
equipped to prevent backflow open channels avoided
Manufacturing and Packaging II Specifically designed and laid out to avoid mixups and cross-contamination
Changing facilities to provide segregated access
MAINTENANCE
Cracks and holes in walls, floors, or ceilings can provide access for insects, rodents, birds, dirt, or microorganisms. Adequately drain areas that may contribute to contamination of food by food borne filth, or provide conditions for nesting and breeding of for pests;
Equipment (Subpart D)
EQUIPMENT DESIGN, SIZE, AND LOCATION: used shall be of: appropriate design, adequate size, suitably located constructed materials shouldnt be reactive, additive, absorptive
lubricants or coolants, shall not come into contact with components, drug product containers, closures, in-process materials, Records shall be kept for maintenance, cleaning, sanitizing, and inspection as specified in 211.180 and 211.182.
References
Good manufacturing practices for pharmaceutics. A Plan for total quality control 4th edition, Revised & Expanded Vol. 78, Sidney H. willing James R Stoker, page 33-51 Quality assurance of pharmaceuticals A compendium of guidelines and related materials Volume 2, 2nd updated edition Good manufacturing practices and inspection-WORLD HEALTH ORGANISATION
Encyclopedia of PHARMACEUTICAL TECHNOLOG Third Edition VOLUME 1, James Swarbick, page 1941 http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ CurrentGoodManufacturingPracticesCGMPs